Insider Purchase: Director at $PVH Buys 600 Shares

PVH director Jesper Andersen purchased 600 shares of PVH stock on June 11, 2025, for approximately $39,660, increasing their holdings by 441.2% to 736 shares; this follows EVP Mark Fischer's sale of 3,186 shares six months prior. Institutional investors showed mixed activity in Q1 2025, with several firms like MASSACHUSETTS FINANCIAL SERVICES and FMR LLC significantly reducing their positions, while PZENA INVESTMENT MANAGEMENT LLC increased its stake. Analyst ratings are currently positive, with Cowen & Co. and Jefferies issuing "Buy" ratings, and a median price target of $95.5.

Analysis

PVH Corp. (PVH) presents a mixed investment signal based on recent activities. A director, Jesper Andersen, significantly increased his stake by 441.2% through a purchase of 600 shares for approximately $39,660 on June 11, 2025, bringing his total holdings to 736 shares. This contrasts with an earlier sale six months prior by EVP Mark Fischer, who divested 3,186 shares for an estimated $336,123. Over the past six months, insider trading has been balanced with one purchase and one sale. Institutional sentiment in Q1 2025 appears largely negative, with 247 institutions decreasing their positions compared to 194 adding shares. Notably, major players like MASSACHUSETTS FINANCIAL SERVICES CO /MA/ reduced holdings by 85.4% (1,825,116 shares), FMR LLC by 26.3% (1,796,924 shares), and ALLIANCEBERNSTEIN L.P. by 90.5% (754,713 shares). Conversely, PZENA INVESTMENT MANAGEMENT LLC increased its stake by 15.1% (807,301 shares). Despite this institutional selling pressure, which contributes to an overall negative sentiment score of -0.4 for PVH, Wall Street analyst ratings remain positive. Cowen & Co. and Jefferies both issued "Buy" ratings in May and June 2025, respectively. The median price target from two analysts over the last six months stands at $95.5, with individual targets ranging from $86.0 (Morgan Stanley, April 2025) to $105.0 (Wells Fargo, February 2025).

Key Decisions for Investors

• Investors should weigh the recent significant insider purchase by a director against the substantial net selling by institutional investors in Q1 2025.
• Consider the bullish analyst ratings and the median price target of $95.5, but remain cautious given the strong institutional outflows and overall negative sentiment score.
• Monitor upcoming institutional holding reports and any further insider transactions for shifts in sentiment or conviction before making significant allocation changes.
• Evaluate individual risk tolerance in light of these conflicting signals, as the director's confidence buy may signal undervaluation, while large institutional sales could indicate perceived headwinds.